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1. Effects of short-term and long-term administration of cycloheximide on rat liver mitochondrial 
protein synthesis have been examined and were found to be different. 
2. Long-term administration of cycloheximide resulted in inhibition of total cellular protein 
synthesis including that of mitochondria while, at short-term intervals, 8 - 10 % of mitochondrial 
protein synthesis was cycloheximide-resistant. 
3 .  The inhibitory effect was also reflected in terms of protein synthesizing ability of mitochondria 
in vitro, the inhibition becoming apparent at 40 min and showing progressive increase with time. 
4. The observed inhibition of mitochondrial protein synthesis by cycloheximide was not due to 
either inhibition of energy metabolism or alteration of amino-acid pool. 
5. Cycloheximide did not enter mitochondria or sonic preparation under conditions in vitro. On 
the other hand, after administration of [3H]cycloheximide, significant quantities of the label were 
found to be associated with mitochondria and mitoribosomes. 
6. These results indicated that cycloheximide reached the site of action in mitochondria under 
conditions in vivo but was unable to do so in vitro. 
7. The results are discussed to elucidate the possible mechanisms involved in the inhibition of 
truly mitochondrial protein synthesis by cycloheximide. 
In recent years it has become apparent that 
mitochondria have their own genetic apparatus and 
an intrinsic protein-synthesizing machinery including 
DNA, RNAs, ribosomes and enzymes involved in 
transcription and translation processes [l - 51. How- 
ever, the amount of genetic information contained in 
mitochondrial DNA is limited and most of the mito- 
chondrial proteins are coded by nuclear genes, syn- 
thesized on cytoplasmic ribosomes and subsequently 
transferred to these organelles [l - 51. During the 
past few years, there have been major advances in 
our knowledge of nucleo-cytoplasmic interactions 
during mitochondrial biogenesis [5,6]. Excellent work 
has been recently carried out on these lines by Mason 
and Schatz [7] and Tzagoloff et al. [8] in yeast. 
These studies emphasize the complex interrelationship 
between mitoribosomal and cytoribosomal protein- 
synthesizing systems during t G  final assembly of a 
mitochondrion. 
Site-specific inhibitors such as cycloheximide and 
chloramphenicol serve as useful tools to study the 
coordination between these two protein-synthesizing 
systems. While chloramphenicol inhibits bacterial 
and mitochondrial protein synthesis [2], cyclohex- 
imide is known to be a potent inhibitor for cytoplasmic 
protein synthesis without having any effect on protein 
synthetic ability of mitochondria in vitro [2]. How- 
ever, in vivo the effect of cycloheximide on mitochon- 
drial protein synthesis often gives variable results 
[9-141. In addition, most of the studies involving 
use of cycloheximide have been carried out with lower 
eukaryotes such as yeast [6,8,13 - 151, Neurospora 
[12,16,17], locust flight muscle [11,18], Tetrahymena 
[19] etc. and Krebs ascites tumor cells [lo] and there 
are only a few reports pertaining to the use of this 
antibiotic in the study of mitochondriogenesis in 
mammalian system [20- 231. 
Present report deals with the effect of cyclohex- 
imide on mitochondrial protein synthesis in rat liver, 
under conditions in vivo and in vitro. These studies 
indicate that the effects of short-term and long-term 
cycloheximide administration on mitochondrial pro- 
tein synthesis are different. At short intervals, cyclo- 
heximide does not inhibit truly mitochondrial protein 
synthesis. On the other hand, long-term treatment 
with cycloheximide results in the inhibition of truly 
mitochondrial protein synthesis, as reflected in terms 
of their protein-synthesizing ability in vitro. The re- 
sults are discussed in relation to the effect of cyclo- 
heximide on mitochondrial protein synthesis per se 
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and also in relation to the interdependence of mito- 
chondrial and cytoplasmic protein synthesis during 
mitochondria1 biogenesis. 
MATERIALS AND METHODS 
Chemicals 
ATP, ADP, sodium dodecylsulfate, sodium suc- 
cinate, acrylamide, N,N'-methylenebisacrylamide, L- 
amino acids, cycloheximide, deoxycholate, Triton 
X-100, 2,5-diphenyloxazole, (PPO), 1,4-bis(-4-methyl- 
5-phenyloxazol-2-yl)-benzene (dimethyl-POPOP) and 
bovine serum albumin were obtained from Sigma 
Chemical Co. (St Louis, Mo., U.S.A.). [3H]Cyclo- 
heximide and ~ ~ - [ l - ' ~ C ] l e u c i n e  (sp cific radioactivity 
47.9 mCi/mmol) were obtained from Isotope Division 
of this Research Centre. [3H]Cycloheximide was 
further purified by thin-layer chromatography using 
butan-1-ol/water (95/5, v/v) as a solvent system and 
identified by co-chromatography of an authentic 
sample. Under these conditions, cycloheximide has 
a RF value of 0.45. The final product had a specific 
radioactivity of 93.8 mCi/mmol. 
All other chemicals used were Analar grade from 
BDH Chemicals Ltd (Dorset, Poole, UK). 
Animals 
Female albino rats of Wistar strain weighing be- 
tween 150- 180 g were used throughout the experi- 
ments. Cycloheximide was dissolved in 0.9% NaCl 
and administered intraperitoneally as indicated. Con- 
trol animals received appropriate amounts of saline. 
Preparation of Subcellular Fractions 
Animals were killed by decapitation and livers were 
quickly removed and chilled in 0.25 M sucrose con- 
taining 10 mM Tris/HCl, pH 7.4 and 1 mM EDTA 
(isolation medium). Mitochondria were isolated es- 
sentially according to the procedure described pre- 
viously [24]. A 10 % homogenate made in isolation 
medium was centrifuged at 650 x g  for 10 min to 
sediment nuclei. Nuclei-free supernatant was centri- 
fuged at 6500 x g for 10 min and resulting mitochon- 
drial pellet was subsequently washed three times by 
suspending in isolation medium and centrifuging at 
6500 x g for 10 min. Mitochondria-free supernatant 
was centrifuged at 18000 x g for 10 min to remove 
residual mitochondrials and the supernatant obtained 
was spun at 105000 x g for 1 h to obtain microsomes. 
Microsomes were washed once by suspending in 
isolation medium and centrifuging at 105000 x g for 
1 h. 
For studies on subcellular distribution of [3H]- 
cycloheximide, the homogenate was filtered through 
four layers of cheese cloth to remove unbroken cells 
and cell debris. Rest of the fractionation procedure 
was as described above, except that total mitochondria 
were obtained by centrifuging at 10000 x g for 10 min. 
Nuclear pellet was washed once. 
Cytoribosomes were prepared according to the 
method of Wettstein et al. [25] and mitoribosomes 
were prepared according to the method of O'Brien [26]. 
All operations were carried out at 0- 4 "C. 
Incorporation Studies 
DL-[I-14C]LeUCine. For studies in vivo, 20 pCi of 
~~- [ I - '~C] l euc ine  (dissolved in 0.9 % NaC1)/100 g 
body weight was administered intraperitoneally and 
animals were sacrificed at the time indicated. In- 
corporation of DL-[ l-'4C]leucine by mitochondria 
in vitro was carried out as described previously [27]. 
For measurement of radioactivity samples were 
spotted on Whatman 3MM filter paper strips (7 cm 
x 1.8 cm), dried in a current of air and processed 
for counting [27]. Radioactivity was counted using 
a scintillator containing 0.3 % PPO and 0.01 di- 
methyl POPOP in toluene, in a Beckman LS-100 
liquid scintillation spectrometer at 95 % efficiency. 
Uptake of( 3H]Cycloheximide 
Experiments in vitro. For studies on uptake in vitro 
of [3H]cycloheximide, three-times-washed mitochon- 
dria were incubated in a medium used for DL-[~- '~C]-  
leucine incorporation [27], except that in place of 
~~- [ l - ' ~C] l euc ine ,  1 pCi of [3H]cycloheximide with or 
without unlabelled cycloheximide (500 pg/ml) was 
added. Uptake of [3H]cycloheximide was measured up 
to 30 min. The reaction was stopped by chilling the 
mixture at the end of incubation periods. Mitochon- 
dria were recovered by centrifugation and were washed 
3 times using isolation medium. 
Experiments in vivo. For subcellular distribution 
studies rats received intraperitoneally 30 pCi of 
[3H]cycloheximide along with 2 mg unlabelled cyclo- 
heximide/100 g body weight and were sacrificed after 
1 h. Subcellular fractions were isolated as described 
above. For 3H counting, samples were directly added 
to vials containing 10 ml of scintillator consisting of 
0.3 % PPO and 0.01 % dimethyl POPOP in toluene/ 
Triton X-100 (2/1, v/v) [28] and counted in a Beckman 
LS-100 liquid scintillation spectrometer at 37 % ef- 
ficiency. 
Protein determination was done by Lowry's 
method [29]. 
Determination of Mitochondria1 Protein Content 
Mitochondria were washed three times and, there- 
fore, could not be recovered quantitatively because of 
operational losses. Hence the method of Gross [30] 
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was used to determine the mitochondrial total protein 
content in a given weight of tissue. This method 
entails the estimation of specific activity of the enzyme 
succinate dehydrogenase in mitochondria, as well as 
the total enzyme activity in the whole homogenate 
[31]. The total mitochondrial protein content is derived 
by rule of three computation. Succinate dehydrogenase 
activity was determined by the method of Caplan 
and Greenwalt [32]. 
Oxidative Phosphorylation 
ADP/O ratio and respiratory control index were 
determined in a Gilson Oxygraph (model KM, 
Gilson Medical Electronics, Middleton, Wis., U.S.A.) 
using succinate as a substrate as described previously 
[24]. ADP/O ratios and respiratory control index 
were calculated as described by Chance and Williams 
P I .  
Determination of Amino-Acid Pool 
Proteins were precipitated with 10% cold tri- 
chloroacetic acid (0- 4 "C), centrifuged and washed 
once with 10% cold trichloroacetic acid (0-4 "C). 
The supernatant and washings were pooled and were 
extracted three times with ether to remove trichloro- 
acetic acid. The trichloroacetic acid soluble material 
was estimated by ninhydrin assay according to Alberti 
and Bartley [34]. 
For measurement of radioactivity, the ether-ex- 
tracted samples were spotted on Whatman 3MM filter 
paper strips and directly counted using a toluene- 
based scintiallator as described above for proteins. 
Dodecylsulfate-Polyacrylamide Gel Electrophoresis 
Dodecylsulfate-polyacrylamide gel electrophoresis 
was carried out by the method of Weber and Osborn 
[35] with some modifications. Details are as described 
elsewhere [36]. 
RESULTS 
Effects of Cycloheximide on ~ ~ - [ I - ' ~ C ] L e u c i n e  
Incorporation in vivo 
In preliminary studies, effects of cycloheximide 
on microsomal and mitochondrial protein synthesis 
in vivo were examined. In these experiments, the 
animals received 0.2 mg cycloheximide/lOO g body 
weight [37,38]. ~~- [ l - ' ~C]Leuc ine  was injected at 
different time intervals as indicated in Table 1. It was 
observed that cycloheximide inhibited microsomal 
as well as mitochondrial protein synthesis to the 
extent of 85% and 90% respectively, by the end of 
1 h. The inhibition increased at 2 h, being about 
95% in both the systems and declined thereafter. 
Interestingly, at 8 h period mitochondrial protein 
synthesis was still inhibited to the extent of 75 %, 
whereas the inhibition of microsomal protein synthesis 
was only 41 %. No inhibition was evident at the end 
of 48 h which may probably be due to detoxification 
of the drug. 
Table 2 shows the effect of cycloheximide con- 
centration on mitochondrial and microsomal protein 
synthesis in vivo. ~ ~ - [ l - ' ~ C ] L e u c i n e  was injected 
intraperitoneally 2 h after cycloheximide administra- 
tion and the animals were killed 1 h later. It can be 
seen that cycloheximide concentration as low as 
50 pg/lOO g body weight brought about 50 inhibi- 
tion in both microsomes as well as mitochondria ; 
higher concentrations resulted in increased inhibition. 
Even under these conditions, almost equal inhibition 
of mitochondrial and microsomal protein synthesis 
was evident. In fact, the inhibition of mitochondrial 
protein synthesis was always slightly higher as com- 
pared to microsomes. Administration of cyclohex- 
imide (1 - 5 mg/lOO g body weight) for 2 h practically 
resulted in stoppage of total cellular protein synthesis 
including that of mitochondria. 
Table 3 gives the effect of shorter time administra- 
tion of cycloheximide (2 mg/100 g body weight) on 
Table 1. Effect of cycloheximide on ~ ~ - ( I - ' ~ C ] l e u c i n e  ncorporation in vivo 
Rats received 20 pCi of DL-[l-'4C]leUCine/100 g body weight intraperitoneally at different time intervals after cycloheximide (0.2 mg/ 
100 g body weight) administration intraperitoneally and were killed 1 h later. Isolation of subcellular fractions and method for counting of 
radioactivity are as detailed in the text. The control animals did not receive cycloheximide. Results are given as typical of four independent 
experiments 
Time Incorporation of ~~- [ l - ' ~C] l euc ine  Inhibition 
. _  _ _  - ~- ~~ 
homogenate mitochondria microsomes homogenate mitochondria microsomes 
~~~~~ ~ 
h 
Control 1692 814 
1 152 122 
2 96 31 
8 738 203 
48 1845 786 
counts x m1n-l x mg protein-' 
_ _  -~ 
3069 
319 
185 
1808 
2740 
% 
91 .O 
94.3 
56.4 
- 
~~ 
85.0 
96.1 
75.1 
- 
89.6 
94.0 
41.1 
- 
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Table 2 Effect of cjcloheuimrde concentration on o~-[ l - '~C]leucrne  incorporation in vivo 
~ ~ - [ l - ' ~ C ] L e u c i n e  (20 pCi/IOO g body weight) was injected 2 h after cycloheximide ddminiStrdtiOn and animals were killed 1 h later Other 
details are as in Table 1 The results are given as mean of 4 independent experiments f S E M 
Cyclohex- Incorporation of o ~ - [ l - ~ ~ C ] l e u c i n e  Inhibition 
imide - ~ -~ _ _  -~~ ~ 
homogenate mitochondria microsomes homogenate mitochondria microsomes 
counts x min x mg protein 'i; 
~~ ~ -~ ~ ~ _ _  -~ 
mg/100 g 
body weight 
0 0  1692 f 121 814 k 81 3289 k 255 
0 025 1506 f 184 687 k 32 3108 k 111 11 0 15 6 5 5  
0 050 809 f 143 397 f 68 1659 k 105 52 2 51 2 49 6 
0 100 523 + 15 210 f 23 1174 k 17 69 1 74 2 64 3 
0 150 114 + 2 4 9 k  2 227 & 12 93 3 94 0 93 1 
~ 150 k 16 - 91 I 95 4 1 00 2 4 k  2 
5 00 - 2 0 +  1 68 + 3 - 91 5 91 9 
Table 3. Ejject of short-term administration n f  cycloheximide on 
o~-[ I - '~C]leuc ine  incorporation in vivo 
Rats received 20 pCi of ~~-[ l - '~C]Ieuc ine / lOO g body weight after 
15 min of cycloheximide (2 mg/100 g body weight) administration 
intraperitoneally and were sacrificed at different time intervals as 
indicated. Other details are as in Table 1. Results are given as 
typical of 4 independent experiments 
Time after Inhibition 
label 
administra- homogenate mitochondrid microsomes 
tion 
~~~~ - 
min 1% 
~~ - ~ ~~ 
2 88 0 83 5 89 5 
5 90 0 87 5 92 0 
8 95 0 89 0 96 0 
15 96 0 90 0 96 0 
mitochondrial and microsomal protein synthesis. 
~ ~ - [ l - ' ~ C ] L e u c i n e  incorporation was studied for 2, 5, 
8 and 15 min after 15 min of cycloheximide administra- 
tion. It can be seen that under these conditions about 
8 - 10 % of mitochondrial protein synthesis was 
cycloheximide resistant (Table 3). Similar results were 
noted when cycloheximide and ~~- [ l - ' ~C] l euc ine  
were injected simultaneously (Fig. 1). On the other 
hand the microsomal protein synthesis was almost 
completely inhibited. However, as studied earlier 
(Table 2), when ~~- [ l - ' ~C] l euc ine  i corporation was 
examined after 2 h of cycloheximide treatment, prac- 
tically complete (98 %) inhibition of total cellular 
protein synthesis, including mitochondrial, was noted. 
It thus became apparent that the short-term (Table 3 
and Fig. 1) and long-term (Table 2) effects of cyclo- 
heximide on mitochondrial protein synthesis in vivo 
were dissociable. While the short-term effect shows 
cycloheximide-resistant mitochondrial protein syn- 
thesis which amounts to 8 to lo%, the long-term 
- 5  
002 6 lb 1; i o  i s  i o  i 5  40 45 
Time a f te r  cycloheximide administrat ion (min) 
Fig. 1, Ejject of' simultaneous injection o j  cyclohexiniidr arid U L -  
[I-'4C]leucine. Animals were simultaneously administered with 2mg 
cycloheximide and 20 pCi of ~~-[ l - '~C] leuc ine / lOO g body weight 
and sacrificed at the time indicated. Control animals received only 
~ ~ - [ l - ' ~ C ] l e u c i n e .  Results are expressed as percentage incorpora- 
tion of control; (O-~o) microsomes; (0-0) mitochondria 
effects bring about inhibition of total cellular protein 
synthesis including that of mitochondria. 
Effect of Cycloheximide Administration 
on Mitochondrial Protein Synthesis in vitro 
To examine whether the observed inhibition of 
mitochondrial protein synthesis in vivo is also reflected 
under conditions in vitro, protein synthetic ability 
of mitochondria isolated from cycloheximide ad- 
ministered animals was studied. Results given in 
Table 4 indicate that mitochondria isolated from 
cycloheximide-treated animals show practically no 
decrease in their protein synthetic ability in vitro 
up to about 20 min, by the end of 40 min about 60% 
inhibition is obs"erved which increases to about 75 
by 2 h. Since the protein synthesizing ability in vitro 
is a measure of the truly mitochondrial protein 
synthesis [2,27], these results, taken together with 
those outlined in Tables 1 and 2, clearly substantiate 
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Table 4. efject of cyclohe.ximide administration on mitochondrial 
protein synthesis in vitro 
Rats received 2 mg cycloheximide/lOO g body weight intraperi- 
toneally and were killed at different time intervals as indicated in 
the table. Incorporation of ~ ~ - [ l - ' ~ C ] l e u c i n e  i vitro was carried 
out for 1 h using 3-times-washed isolated mitochondria as de- 
scribed in the text. Incorporation by isolated mitochondria from 
control animals (zero time) was 271 f 22 counts x min-' x mg 
protein-'. Results are averages of 6 independent experiments. 
+ sign indicates stimulation in the incorporation activity in vitro 
Time after 
cycloheximide 
administration 
Inhibition 
min 
0 
5 
10 
15 
20 
40 
60 
120 
% 
+ 9.1 
+ 6.8 
+ 1.6 
10.0 
61.4 
71.3 
74.7 
Table 5. Effect of cycloheximide in vivo on mitochondrial oxidative 
metabolism 
Animals were sacrificed 2 h after cycloheximide administration 
(2 mg/100 g body weight). Rates of respiration in presence and 
absence of ADP were determined using succinate as  substrate [24]. 
Calculation of ADP/O ratio and respiratory control index was 
according to Chance and Williams [33]. Results are given as mean 
of 5 independent experiments k S.E.M. 
Cyclo- ADP/O ratio Rate of oxidation Respira- 
hexi- 
mide + ADP - ADP control 
- tory ~ ~ 
index 
mg/l00g nmolO2 x min-' 
body x mg protein-' 
weight 
0 1 .58k0.18  56.0k3.40 14 .6k0 .34  3.84 
2 1 .50k0.03  64 .8k3 .15  15.3k0.10 4.23 
5 1 .53f0 .12  55.5+3.21 14 .8k0 .29  3.75 
- ~- 
the inference that at long-term intervals, cycloheximide 
indeed inhibits the protein-synthesizing ability of 
mitochondria. 
The observed inhibition of mitochondrial protein 
synthesis in vivo as well as in vitro after cycloheximide 
treatment may be due to several reasons. These in- 
clude : interference with energy metabolism of mito- 
chondria; alteration of amino-acid pool size; inhibi- 
tion of mitochondrial protein synthesis per se; and 
interdependence of mitochondrial and microsomal 
protein synthesis. The first three possibilities were 
tested in the subsequent studies. The alternative 
possibility of interdependence is considered under 
'Discussion'. 
Mitochondria1 Oxidative Metabolism 
Table 5 gives the ADPjO ratio and respiratory 
control index for mitochondria isolated from normal 
and cycloheximide-treated animals. Cycloheximide 
concentrations (2 and 5 mg/100 g body weight) which 
almost completely inhibit total cellular protein syn- 
thesis (Table 2), did not show any effect on ADPjO 
ratios, rate of oxygen consumption in presence and 
absence of ADP and respiratory control index. Thus, 
it appears that even at these high concentrations 
cycloheximide does not interfere with energy metab- 
olism of mitochondria. 
Amino-Acid Pool Size 
Preliminary experiments to correlate the decreased 
incorporation with amino acid pool of mitochondria 
indicated that the specific activity of the mitochondrial 
pool was always higher in the cycloheximide-treated 
rats (Table 6). The pool-size, however, could not be 
assessed correctly because of losses during washings 
(Table 6). As an alternative and nearest approach, 
we tried to correlate the observed changes with the 
homogenate pool. 
Table 6. Effhct qf cycloherimide administration on amino acid pool of mitochondria 
Animals were administered 2 mg cycloheximide/100 g body weight intraperitoneally 2 h prior to injection of 20 pCi of o~-[l- '~C]leucinejIOO g 
body weight and were sacrificed 1 h later. Control animals received only ~ ~ - [ l - ' ~ C ] l e u c i n e .  Amino acids were estimated by 'ninhydrin' 
method [34] as described in the text. Results are given as  mean k S.E.M. of 4 independent experiments performed in duplicate 
Mitochondria Amino acid content Incorporation of ~ ~ - [ l - ' ~ C ] l e u c i n e  
~ - _  - ~ ~ - 
normal cycloheximide- normal cycloheximide- 
treated t red ted 
pg x mg mitochondrial protein-' counts x min ' x l g  amino acid-' 
~ ~ _ _  - -. ~ _ .  ~- - -~ 
Once-washed 10 92 k 0 28 9 1 1  * 0 6 0  5 5 1  f 0 4 4  8 13 f 0 8 9  
Thrice-washed 8 82 f 0 53 6 36 f 0 61 4 2 1  * 0 2 1  6 8 0  * 0 7 1  
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Table I .  Effect o j  cycloheximide administration on amino-acid pool size of liver homogenate 
The experimental details are as described in Table 6. Mitochondrial protein content was determined by the method of Gross [30] as detailed 
in the text and values are given as typical of 5 independent experiments. Other results are given as mean i S.E.M. of4 independent experiments 
performed in duplicate 
Group Amino-acid Mitochondrial Incorporation of DL-[ l-'4C]leucine Relative 
content proteins - specific 
a b activity 
(sib) 
pg x g liver-' mg x g liver-' counts x min-' x mg 
mitochondrial protein-' amino acid-' 
counts x min-' x pg 
Control 6366 291 41.8 1048.7 k 21.5 8.18 f 0.29 128.20 
Cycloheximide-treated 10789 3- 718 41.2 39.9 f 1.9 17.19 f 0.98 2.32 
It was observed that administration of cyclo- 
heximide resulted in about 70% increase in the pool 
size of the homogenate and the specific activity of the 
pool became approximately two-fold (Table 7). How- 
ever, in spite of the increase in the pool size and 
in its specific activity the incorporation into mito- 
chondria decreased to the extent of 96 %. This is 
also reflected in terms of a tremendous decrease in the 
relative specific activity from 128 to 2.3 (Table 7). 
Mitochondrial protein content of the liver, however, 
remained unaffected under these conditions as is to 
be expected. Thus notwithstanding the limitations 
that the homogenate pool can not strictly be related 
to the mitochondrial pool, the results obtained in 
the present experiment with mitochondria and homo- 
genate indeed indicate that the observed decrease in 
mitochondrial protein synthesis may not be due to the 
alterations of the pool size. The possibility of cyclo- 
heximide inhibiting mitochondrial protein synthesis 
per se was next examined. 
The foregoing studies (Tables 1 , 2  and 4) indicated 
that cycloheximide may indeed be affecting truly 
mitochondrial protein synthesis. On the other hand, 
it is known that cycloheximide when added in vitro, 
does not inhibit the protein-synthesizing activity of 
isolated mitochondria [27] (Table 8). These observa- 
tions raised a possibility that such a differential 
effect of cycloheximide under conditions in vivo and 
in vitro may be due to permeability barrier across 
the mitochondrial membranes. This was tested by 
examining effect of cycloheximide addition to soni- 
cated mitochondria on their protein-synthesizing ac- 
tivity. 
Results in Table 8 show that sonication by itself 
resulted in about 55 % decrease in the incorporation 
by mitochondria in vitro. This may be because of loss 
of structural integrity. However, addition of cyclo- 
heximide to sonicated mitochondria and/or sonica- 
tion of mitochondria in presence of cycloheximide 
did not significantly affect their incorporation ability 
in vitro. It may be that even under these conditions, 
Table 8. Effect of cycloheximide on n~-[ l - '~C]leuc ine  incorporation 
in vitro by sonicated mitochondria 
Mitochondria were sonicated at 0-4°C in a MSE ultrasonic 
disintegrator at 1.8 kHz for 2 min (30 s, 4 times) in the absence 
or presence of cycloheximide. Final concentration of cycloheximide 
in incubation medium was 500 pg/ml. Incorporation in vitro was 
carried out as described in the text at 30 "C for 1 h. Results are given 
as typical of 5 independent experiments 
Mitochondria Incorporation of Inhibition 
DL-[l-'4C]leUCine 
counts x min-' % 
x mg protein-' 
Control 26 1 
Control + cycloheximide 243 
Sonicated 117 
Sonicated + cycloheximide 115 
Sonicated in presence 
of cycloheximide 147 
5.7 
55 
56 
44 
cycloheximide fails to reach the site of action and 
perhaps the transfer is mediated by a carrier. In order 
to verify this possibility, experiments were carried out 
using 105000 x g supernatant in the incubation system. 
However, addition of cycloheximide along with cell- 
sap or addition of cell-sap from cycloheximide- 
treated animals, also did not affect the incorporation 
ability of the mitochondria in vitro (Table 9). These 
results thus indicated that cycloheximide fails to reach 
the site of action under conditions in vitro probably 
because the carrier may function only in vivo; alterna- 
tively, cycloheximide may be entering mitochondria 
in vivo independently of a hypothetical carrier. These 
possibilities were further explored by following the 
uptake of [3H]cycloheximide in vitro and in vivo. 
Studies on uptake of [3H]cycloheximide by mito- 
chondria in vitro, in the absence or presence of 
unlabelled cycloheximide (500 pg/ml) are summarised 
in Tables 10 and 11, respectively. It was observed 
that negligible amount of radioactivity is associated 
with mitochondria, the activity being practically the 
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Table 9. Effect of cell sap on ~ ~ - [ l - ' ~ C ] l e u c i n e  incorporation in vitro 
by mitochondria 
Animals were injected with 2 mg cycloheximide/100 g body weight 
intraperitoneally 1 h prior to sacrifice. Incorporation of DL-[1-'4C]- 
leucine in vitro into mitochondrial proteins was carried out for 1 h 
at 30 "C. Results are typical of 5 independent experiments 
Addition Incorporation of Inhibition 
DL- [ 1 -'4C]leucine 
counts x min-' % 
x mg protein-' 
None 253.0 
+ 0.2 ml cell sap 
(from control animal) 248.0 
+ 0.2 ml cell sap 
(from cycloheximide-treated 
animal) 254.0 
(from cycloheximide-treated 
animal) 250.0 
+ 0.5 ml cell sap 
2.0 
0.0 
1.3 
Table 10. Uptake of [3H]cycloheximide in vitro by mitochondria 
1 pCi of [3H]cycloheximide was added to the mitochondrial pro- 
tein-synthesizing system in vitro as indicated in the text except that 
~~- [ l - ' ~C] l euc ine  was omitted and cold leucine was included in the 
amino acid mixture. Uptake was studied at 30 "C for up to 30 min. 
At the end of incubation, mitochondria were washed three times 
with 0.25 M sucrose containing 10 mM Tris/HCl, pH 7.4 and 
1 mM EDTA. Radioactivity was counted in a toluene/Triton 
scintillator system as indicated in the text. Results are given as 
mean f S.E.M. of 4 independent experiments 
Incubation time Uptake of Uptake 
[3H]cycloheximide 
min counts x min-' x mg protein-' 
0 143.0 f 7.20 0.197 
5 225.0 f 17.20 0.219 
15 253.0 k 5.37 0.255 
30 309.0 f 6.90 0.351 
same in the absence (Table 10) and in the presence 
(Table 11) of the carrier cycloheximide. This probably 
indicates a simple tritium exchange. This possibility is 
further supported by the fact that the exchange level 
at 0 h and 30 min shows only a marginal difference 
(Tables 10 and 11). These results therefore substantiate 
the view that cycloheximide does not enter mitochon- 
dria under conditions in vitro. 
The possibility of cycloheximide entering into the 
mitochondria under conditions in vivo was then in- 
vestigated by studying subcellular distribution of 
injected [3H]cycloheximide. The results in Table 12 
show that although most of the label (75 %) is present 
in cell sap, about 4 % and 8 % of it is associated with 
mitochondria and microsomes, respectively (Table 12). 
It is therefore apparent that cycloheximide may be 
entering into mitochondria under conditions in vivo. 
Preliminary studies revealed that significant radio- 
activity was associated with both, cytoribosomes and 
Table 11. Uptake of [3H]cycloheximide in vitro by mitochondria 
in presence of unlabelled cycloheximide 
Uptake of [3H]cycloheximide in vitro was carried out as indicated 
in Table 10 except that 500 pg of unlabelled cycloheximide/ml of 
incubation medium was added along with 1 pCi of [3H]cyclo- 
heximide. Other details are as in Table 10. Results are given as 
mean & S.E.M. of 4 independent experiments 
Incubation time Uptake of [3H]cyclohexirnide Uptake 
min 
0 
5 
15 
30 
counts x min-' x mg protein-' 
198.0 f 2.8 
316.0 f 8.6 
356.0 k 16.0 
386.0 k 13.1 
0.226 
0.296 
0.311 
0.333 
Table 12. Association of [ 3H]cycloheximide in vivo with subcellular 
fractions of rat liver 
Animals received intraperitoneally 30 VCi of [3H]cycloheximide 
(+ 2 mg unlabelled cycloheximide)/lOO g body weight 1 h prior 
to sacrifice. Mitoribosomes and cytoribosomes were isolated as 
described in the text. Radioactivity was counted in a toluene/Triton 
scintillator system as described in the text. Recovery of [3H]cyclo- 
heximide in the subcellular fractions was calculated as a percentage 
by comparing the total number of counts in the fractions with 
those found in total liver homogenate. Results are given as mean 
f S.E.M. of 3 independent experiments 
Fraction Uptake of Recovery 
[3H]cycloheximide 
counts x min-' x mg % 
protein-' 
Homogenate 2310.3 k 405.0 100.0 
Nuclei 192.7 f 27.1 2 
Mitochondria 306.0 _+ 30.4 4 
Microsomes 825.6 f 90.1 8 
Cell sap 5869.6 f 245.0 15 
- Mitoribosomes 91 +_ - 
Cytoribosomes 412 +_ - - 
mitoribosomes (Table 12). The specific activities, how- 
ever, were less than those of microsomes and mito- 
chondria. This is understandable in view of the fact 
that fractionation of ribosomes involved treatment 
with detergents and loss of radioactivity may have 
occurred during this treatment. However, the fact 
remains that significant activity is still associated with 
both cytoribosomes and mitoribosomes (Table 12). 
DISCUSSION 
The inhibitory effect of cycloheximide on ribo- 
somal protein synthesis is well recognised [2,4]. 
Recently, however, it is becoming increasingly evident 
that besides its effect on ribosomal protein synthesis, 
cycloheximide may exert multiple effects. Thus, it 
has been reported that cycloheximide inhibits syn- 
thesis of 16 S ribosomal RNA in L cells [39] and in 
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rat liver [40] and of nuclear RNA [41] and chromatin 
[42] in HeLa cells. in Chlorella, cycloheximide is 
known to inhibit selectively nuclear DNA synthesis 
[43]. inhibition of both mitochondrial as well as 
cytoplasmic ribosomal RNA species in Tetrahymena 
by cycloheximide has been reported [19]. Changes in 
the ultrastructure of rat liver cells within 6 h after 
administration of cycloheximide have also been 
noted [44]. Results presented in this paper bring out 
yet another aspect of cycloheximide action. 
It is clear from the present studies that the 
short-term and long-term effects of cycloheximide on 
mitochondrial protein synthesis are dissociable 
(Tables 2 and 3, Fig. 1). After short-term treatment 
with cycloheximide, up to 8 - 10 % of mitochondrial 
protein synthesis is discernible (Table 3, Fig. l), an 
observation consistent with that of several other 
workers [lo-12,20-2221. This has been shown to be 
identical to the protein-synthesizing ability in vitro 
of isolated mitochondria and, therefore, taken to 
represent the truly mitochondrial protein synthesis 
[2]. On the other hand, long-term treatment with 
cycloheximide leads to practically complete stoppage 
of truly mitochondrial protein synthesis (Table 2), 
which is also reflected in their protein synthesizing 
activity in vitro (Table 4). The results, therefore, 
besides supporting the observations that mitochondria 
can synthesize only 8 - 10 % of their proteins [2- 61, 
also point to the complexities in the use of cyclo- 
heximide. In this context, it is of interest to note that 
Kroon and Arendzen have observed that ‘in case of 
side effects of antibiotics influencing at one or another 
level with mitochondrial biogenesis one should serious- 
ly consider whether the arrest of mitochondrial devel- 
opment is the cause underlying the toxic signs’ [45]. 
Inhibition of mitochondrial protein synthesis after 
cycloheximide treatment has also been reported re- 
cently in lower eukaryotes. Ibrahim et al. [46] observed 
a 50 % decrease in the protein synthesis by yeast mito- 
chondria in vitro [46]. In their experiments, partially 
derepressed cells were grown in cycloheximide for 
3 h followed by transfer to fresh medium for 1-2 h 
prior to the isolation of mitochondria. In Tetrahy- 
mena, even a 5-min incubation with cycloheximide 
could lead to decreased incorporation activity of the 
isolated mitochondria. After the cells had been treated 
for 30 min, more than 50 % of the activity was lost [19]. 
The possibility of a cycloheximide effect on truly 
mitochondrial protein synthesis being due to inter- 
ference with energy metabolism or arising as a result 
of changes in the amino acid pool seems unlikely 
in view of the data presented (Tables 5 and 6 and 7 
respectively). Under conditions in vitro, cyclohex- 
imide did not enter the site of action, even in the 
presence of added cell sap (Table 9). However, when 
injected in vivo, sizable amounts of cycloheximide were 
found to be associated with mitochondria and micro- 
somes (4 % and 8 %, respectively). Interestingly, signif- 
icant activity is found to be associated with mito- 
ribosomes and cytoribosomes (Table 12). Contrary to 
the observation reported here, Ashwell and Work [lo] 
found that an assayable amount of cycloheximide 
was associated with mitochondria after incubation 
with the antibiotic in vitro. We are unable to explain 
the reason for such a discrepancy at the present 
time. However, from our present results (Tables 10- 
12) it would seem that cycloheximide is able to reach 
the site of action (presumably mitoribosomes) only 
under in vivo conditions. These studies, however, 
do not indicate whether the process of cycloheximide 
association with mitochondria in vivo involves a 
carrier or is independent of it. it is also likely that 
[3H]cycloheximide may be entering into mitochondria 
non-specifically and without having any inhibitory 
action per se [47] and that the observed inhibition 
of mitochondrial protein synthesis in vivo might be 
due to interdependence of mitochondrial and micro- 
soma1 protein-synthesizing systems. Such a line of 
thinking is further borne out by observations reported 
in Table 4. One interesting feature of these findings 
is that cycloheximide did not inhibit mitochondrial 
protein synthesis up to about 40 min, after its adminis- 
tration. Probably these results illustrate the depen- 
dence of mitochondrial protein synthesis on cyto- 
plasmically synthesized partner proteins. It may be 
that there is enough of partner proteins to last for up 
to 40 min after cycloheximide administration, when 
the effect of cycloheximide becomes apparent. In 
other words, some cytoplasmically synthesized prod- 
uct(s) required for continuation of mitochondrial 
protein synthesis [l5] might be short-lived and getting 
exhausted within 40 min or so. Interdependence of 
the mitochondrial and cytoplasmic protein-synthesiz- 
ing systems during biogenesis of mitochondrial en- 
zymes such as cytochrome oxidase [48-501 and 
ATPase [8] has been amply emphasized by Schatz 
and Mason in their recent review [6]. 
With a view to finding out the possibility whether 
the synthesis of partner proteins is inhibited after 
cycloheximide treatment, dodecylsulfate-polyacryl- 
amide gel electrophoresis was carried out using various 
subcellular components such as whole mitochondria, 
mitochondrial membranes, microsomes and cell sap 
isolated from normal as well as cycloheximide-in- 
jected animals (2 mg/100g body weight for 1 h). 
Preliminary studies, however, indicated that the pos- 
sible short-lived protein product(s) could not be 
detected by this method. No differences were observed 
in the number of bands as well as peak height in the 
protein profiles (microdensitometric scans) obtained 
for normal and cycloheximide-treated animals in 
mitochondria, mitochondrial membrane proteins as 
well as microsomal and cell sap proteins (Fig.2). 
Probably, such product(s) may exist in trace quantitites 
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Fig. 2. Tqpical dodec,)~lsuifate-polyucrylumide gel photograph showing 
polypeptide patterns obtained .for mitochondria (M),  mitochondrial 
membranes ( M m j ,  microsomes ( M s j  and supernatant (S j  from 
( a j  normal and (b j  cycloheximide-treated ruts. Other details are as 
described in the text 
and/or escape detection because of the fact that they 
may have the same molecular weight as that of other 
proteins which makes it difficult to detect them or 
separate them from other subunit proteins. 
The possibility that under the influence of cyclo- 
heximide, the hydrophobic proteins (products of 
mitochondrial protein synthesis) could not leave the 
mitoribosomes unless they are pulled off by corre- 
sponding cytoplasmically synthesized subunit pro- 
teins and remain attached to mitoribosomes thereby 
making them unavailable for further protein synthesis 
has also to be be considered in this context [6]. 
Alternately, the short-lived product might be a 
messenger-RNA, a translation product of mitochon- 
drial DNA [51], whose half-life has been shown to be 
about 15 min in yeast [52]. It could also be a ribosomal 
RNA, since, cycloheximide is known to inhibit the 
synthesis of both mitochondrial as well as cytoplasmic 
ribosomal RNA species in Tetrahymena [19]. These 
possibilities, however, have not been verified experi- 
mentally and need further exploration. 
The possibility that metabolites of cycloheximide 
may be responsible for the inhibition of mitochondrial 
protein synthesis seems to be unlikely in view of the 
experiments outlined in Table 9 where mitochondria 
were incubated with cell sap from cycloheximide- 
treated animals and had no affect on their protein- 
synthesizing ability in vitro. 
Although in the present investigations the reason 
for inhibition of mitochondrial protein synthesis by 
cycloheximide could not be pin-pointed, the results 
have ruled out interference with energy metabolism 
and amino-acid pool as possible causes. Besides, 
these studies have clearly dissociated short-term and 
long-term effects of cycloheximide, thus emphasizing 
the complexity of inhibitor action as pointed out by 
Kroon and Arendzen [45]. Needless to say, further 
exploration of cycloheximide effects on mitochondrial 
RNA metabolism would help to shed more light 
on the mechanism of inhibition of mitochondrial 
protein synthesis by cycloheximide. 
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